EC/FDA joint inspections

被引：0

|

作者：

Barbara Nasto

机构：

来源：

Nature Biotechnology | 2008年 / 26卷 / 8期

关键词：

D O I：

10.1038/nbt0808-847b

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：847 / 847

相关论文

共 50 条

[31] Joint inspections still cool
Suzanne Elvidge
Nature Biotechnology, 2010, 28 (11) : 1140 - 1140
[32] The FDA-483: History and use in drug inspections
Cooper, D
PDA JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, 1996, 50 (06): : 386 - 390
[33] HARMONIZING OF INSPECTIONS WITHIN THE EC-MEMBER STATES
BLASIUS, H
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (04) : 168 - 169
[34] FDA promotes shorter PMA summaries, faster inspections
Dickinson, James G.
Medical Device and Diagnostic Industry, 1998, 20 (12):
[35] FDA inspections find unsafe practices in compounding pharmacies
McCarthy, Michael
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[36] The nuts and bolts of FDA inspections - Before, during, and after
Christensen, JR
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (08): : 44 - 46
[37] FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections
Haigney, Susan
BIOPHARM INTERNATIONAL, 2013, 26 (05) : 10 - 10
[38] FDA Faces Huge Task Catching Up on Inspections
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2022, 35 (03) : 9 - 9
[39] FDA inspections of drug products and active pharmaceutical ingredients
Kirrstetter, R
PHARMAZEUTISCHE INDUSTRIE, 2004, 66 (10): : 1260 - +
[40] FDA revises inspections and compliance policies for drugs and biologics
Wechsler, J
BIOPHARM INTERNATIONAL, 2003, 16 (11) : 14 - +

← 1 2 3 4 5 →